How to cite item

Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard

   
@article{ATM6803,
	author = {Deniz Yalman and Ugur Selek},
	title = {Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard},
	journal = {Annals of Translational Medicine},
	volume = {3},
	number = {11},
	year = {2015},
	keywords = {},
	abstract = {The standard treatment for operable, early stage non-small cell lung cancer (NSCLC) is surgical resection, usually lobectomy, with mediastinal lymph node sampling or dissection. However, significant surgical toxicity had been noted in these patients with 90-day mortality rates exceeding 30-day rates. There is also a risk of disease recurrence ranging from 6% to 10% per person-year during the first 4 years after surgery as stated by Lou et al. after an analysis of 1,300 patients who underwent surgery.},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/6803}
}